France Launches Alliance to Accelerate Immunotherapy Development
Partnership aims to speed progress from research to treatment
A new alliance in France has been established to fast-track immunotherapy from laboratory research to clinical application, combining resources from government, academia, and industry.
The initiative seeks to position France as a global leader in advanced cancer and immune-related treatments.